Welcome to our dedicated page for Garden Stage Ltd. SEC filings (Ticker: GSIW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Garden Stage Limited (NASDAQ: GSIW) provides access to the company’s publicly filed documents as a foreign private issuer. Garden Stage submits current reports on Form 6-K and uses registration statements such as Form F-1 and Form F-3 in connection with offerings of its ordinary shares. These filings describe a Cayman Islands holding company operating through Hong Kong-based subsidiaries engaged in placing and underwriting, securities dealing and brokerage, asset management, and investment advisory services.
Among the key documents available are Form 6-K reports detailing registered direct offerings of ordinary shares and, in some cases, pre-funded warrants. These filings set out the number of shares issued, purchase prices, net proceeds, and stated intended use of proceeds, which the company has described as working capital and general corporate purposes. Related exhibits, such as securities purchase agreements and legal opinions regarding the validity of securities being registered, are also included in the filing record.
Other Form 6-K submissions cover corporate governance and capital structure matters. Examples include reports on extraordinary general meeting results approving the redesignation of authorized share capital into different classes of ordinary shares, adoption of a second amended and restated memorandum and articles of association, authorization of updates to the register of members and filings in the Cayman Islands, and approval of a potential consolidation of Class A ordinary shares within a specified ratio range. Filings also document board and executive appointments and the associated directorship agreements, which outline compensation and obligations such as confidentiality and adherence to the company’s code of business conduct and ethics.
Investors can use these filings to follow Garden Stage’s capital-raising activities, changes in share capital and governance documents, and other material agreements, such as share purchase agreements for acquisitions disclosed in Form 6-K. The page also surfaces filings related to the company’s Nasdaq listing status, including documents that describe minimum bid price notifications and compliance updates. Stock Titan’s tools can help summarize and highlight the main points in lengthy filings, making it easier to identify information on registered offerings, corporate actions, and key contractual arrangements without reading every page in detail.
Garden Stage Limited has completed a registered direct offering on June 17, 2025, raising approximately $3.58 million in net proceeds. The company sold 6.1 million ordinary shares at $0.60 per share to selected investors through Securities Purchase Agreements.
The offering was conducted under the company's Form F-3 registration statement (File No. 333-283618), which was declared effective by the SEC on March 10, 2025. The net proceeds will be used for working capital and general corporate purposes.
Key details of the transaction:
- Share price: $0.60 per ordinary share
- Total shares issued: 6.1 million
- Net proceeds: $3.58 million after expenses
- Closing date: June 17, 2025
The filing includes standard representations, warranties, and forward-looking statements disclaimers. The transaction was supported by legal opinion from Travers Thorp Alberga, the company's Cayman Islands counsel.
Garden Stage Limited announces a self-underwritten offering of 6.1 million ordinary shares at $0.60 per share. The company's shares (NASDAQ: GSIW) closed at $1.48 on June 17, 2025, with a public float value of approximately $29.4 million.
Key points about the offering:
- Company is a Cayman Islands holding company operating through Hong Kong subsidiaries I Win Securities and I Win Asset Management
- No direct operations or presence in mainland China
- Stock has experienced significant volatility, with 52-week range of $0.38-$12.30
- Not subject to PRC regulatory oversight, including CSRC and CAC requirements
Notable risks include potential future PRC regulatory intervention in Hong Kong operations, PCAOB audit inspection requirements, and delisting risks under the HFCAA. The company's current auditor, J&S Associate PLT (Malaysia), is PCAOB-inspectable, reducing immediate delisting concerns.